ArticleGynecologic oncology2025
No increase in chronic kidney disease after postoperative acute kidney injury in gynecologic oncologic ERAS surgery.
Article in Gynecologic oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term risks of major adverse cardiovascular events after acute kidney injury: a systematic review and meta-analysis.Clinical kidney journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo compare development of long-term chronic kidney disease (CKD) and cardiac conditions postoperatively among patients who did and did not develop acute kidney injury (AKI) after open ERAS surgery for gynecologic malignancy.
methodsWe compared patients with and without postoperative AKI within 30 days of open surgery for gynecologic malignancies using ERAS protocols from March 2016-December 2018 at a single academic institution. We estimated 36-month cumulative incidence of renal and cardiac conditions for each cohort. We compared cohorts using comparative statistics and performed univariate and multivariate analyses on time to development of CKD.
resultsAmong 378 patients, 51 (13.5 %) developed postoperative AKI. Over a median follow-up of 19.4 months (range 0.1-59.2 months), patients with AKI were twice as likely to develop CKD (p < 0.001). There was no difference in development of any cardiac condition (p = 0.74) between patients with and without AKI. The cumulative incidence of CKD at 36 months was 23.4 %. On univariate analysis, patients with AKI were more likely to develop CKD (HR = 2.17, 95 % CI 1.22-3.84) but AKI was not significantly associated with CKD on multivariate analysis. Older age (p < 0.001), body mass index ≥30 kg/m
conclusionWe found no differences in long-term renal or cardiac conditions between patients with and without postoperative AKI after open ERAS surgery for gynecologic malignancies. Factors other than postoperative AKI appear more important in CKD development in patients with gynecologic cancers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.